This grant is for the purpose of advancing research into pediatric drug formulations and innovative drug delivery systems, addressing critical needs across various age groups. The National Institutes of Health (NIH) seeks proposals focused on enhancing the acceptability and efficacy of medications for children. Investigators are encouraged to explore novel approaches, concepts, and techniques that surpass current methods in pediatric formulation development and testing. This funding opportunity supports exploratory and innovative research initiatives designed to improve drug administration and treatment outcomes specifically for the pediatric population. The goal is to foster the development of child-friendly medicines, ensuring appropriate dosage forms and delivery mechanisms are available to meet the unique physiological requirements of infants, children, and adolescents.
Opportunity ID: 292830
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-192 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 29, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) City or township governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments County governments Private institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field. Applications submitted under this mechanism should be exploratory and novel. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-192.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231698 | May 16, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00236238 | Nov 15, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260049 | May 16, 2017 | May 07, 2020 | View |
Package 1
Mandatory forms
292830 RR_SF424_2_0-2.0.pdf
292830 PHS398_CoverPageSupplement_3_0-3.0.pdf
292830 RR_OtherProjectInfo_1_3-1.3.pdf
292830 PerformanceSite_2_0-2.0.pdf
292830 RR_KeyPersonExpanded_2_0-2.0.pdf
292830 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292830 RR_Budget_1_3-1.3.pdf
292830 RR_SubawardBudget30_1_3-1.3.pdf
292830 PHS398_ModularBudget_1_2-1.2.pdf
292830 PHS_Inclusion_Enrollment_Report-1.0.pdf
292830 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292830 RR_SF424_2_0-2.0.pdf
292830 PHS398_CoverPageSupplement_4_0-4.0.pdf
292830 RR_OtherProjectInfo_1_4-1.4.pdf
292830 PerformanceSite_2_0-2.0.pdf
292830 RR_KeyPersonExpanded_2_0-2.0.pdf
292830 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292830 RR_Budget_1_4-1.4.pdf
292830 RR_SubawardBudget30_1_4-1.4.pdf
292830 PHS398_ModularBudget_1_2-1.2.pdf
292830 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
292830 RR_SF424_2_0-2.0.pdf
292830 PHS398_CoverPageSupplement_5_0-5.0.pdf
292830 RR_OtherProjectInfo_1_4-1.4.pdf
292830 PerformanceSite_2_0-2.0.pdf
292830 RR_KeyPersonExpanded_2_0-2.0.pdf
292830 PHS398_ResearchPlan_4_0-4.0.pdf
292830 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
292830 RR_Budget_1_4-1.4.pdf
292830 RR_SubawardBudget30_1_4-1.4.pdf
292830 PHS398_ModularBudget_1_2-1.2.pdf
292830 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
